Using fMRI to study brain development

	Tweet

Functional magnetic resonance imaging (fMRI) is a powerful noninvasive tool for studying brain activity in both humans and experimental animals. Most fMRI studies are carried out on adults, but this technique also has great potential for studying early brain development. That potential is hampered, however, by a lack of knowledge about the basis of the fMRI signal in the developing brain. Now, by studying rats, MIT neuroscientists show that the fMRI signal changes during first few weeks of life. By correcting for those changes, the researchers were able to monitor the development of the rat brain. Determining whether analogous changes occur in humans will be important for interpreting developmental fMRI studies in young children.

“Our study lays a foundation for using fMRI to study development,” explains senior author Alan Jasanoff, Associate Member of the McGovern Institute and Assistant Professor of Nuclear Science and Engineering .

“It establishes an approach that others can apply to investigate many aspects of neurodevelopment in very young animals.” Jasanoff collaborated with the lab of developmental biologist Martha Constantine-Paton, a McGovern Institute Principal Investigator. The study was published online November 25, in the journal Nature Neuroscience.

A fundamental difficulty in interpreting fMRI is that it provides only an indirect readout of brain activity, based on changes in the brain’s blood supply. Increases in brain activity cause increased blood flow, but the coupling mechanism that links these two processes is itself subject to change in early life. Thus, a weak fMRI signal in young animals could mean less neural activity, or it could simply mean that MRI cannot detect that activity because of weak neurovascular coupling.

To resolve this uncertainty, Jasanoff and colleagues compared fMRI signals with direct electrical recordings of neuronal activity as they stimulated rats’ forepaws. In animals younger than 11 days, they could not detect fMRI signals, even though electrical recordings showed that the brain was responding to stimulation. The fMRI signals became both stronger and faster as the animals matured, until they approached adult levels by about 3 weeks of age. This corresponds approximately to 7-8 years in terms of human brain development.

By compensating for these age-related changes, the authors were able to track the development of connections between different touch-sensitive brain regions as the animals matured.

The researchers also investigated what molecular events might underlie the changing relationship between neural activity and the blood response. Their findings suggest that a key player is carbonic anhydrase (CA), a well-known enzyme that helps remove carbon dioxide from the blood. Age-related increases in CA activity corresponded to the changes in the fMRI signal, and drugs that block the activity of this enzyme in adult animals caused the fMRI signal to “regress” to that seen in younger animals. CA is an important target for drugs used to treat diverse conditions, including glaucoma, altitude sickness and epilepsy, so it will be interesting to determine whether such drugs alter the relationship between activity and blood flow in the adult human brain.

In the longer term, Jasanoff hopes to circumvent the difficulties of fMRI altogether, by developing new methods that will make it possible to visualize neural activity directly, rather than indirectly through its effect on blood flow.

###

Matthew Colonnese, a former post doctoral associate with Constantine-Paton and Jasanoff, was the lead author on the study; Marnie Phillips, a postdoctoral researcher in Constantine-Paton’s lab, and Kai Kaila at University of Helsinki also contributed. The study was supported by the McGovern Institute and the Whitehead Institute for Biomedical Research.

About the McGovern Institute

The McGovern Institute for Brain Research at MIT is led by a team of world-renowned, neuroscientists committed to meeting two great challenges of modern science: understanding how the brain works and discovering new ways to prevent or treat brain disorders. The McGovern Institute was established in 2000 by Patrick J. McGovern and Lore Harp McGovern, who are committed to improving human welfare, communication and understanding through their support for neuroscience research. The director is Robert Desimone, formerly the head of intramural research at the National Institute of Mental Health.

Contact: Charles Jennings

617-324-3977
McGovern Institute for Brain Research

RELATED STORIES:
When work interferes with life   Demystifying Meditation – Brain Imaging Illustrates How Meditation Reduces Pain   Glucosamine-like supplement suppresses multiple sclerosis attacks   Study shows brain anticipates taste   Study shows how memory is disrupted in those with disease linked to learning disabilities   An early step in Parkinson’s disease: Problems with mitochondria   Parents of Children With Disabilities Face More Daily Stress   People can change some stroke risk factors   Stroke awareness campaign aims to halve deaths   Computer test accurately detects early Alzheimer’s   Young have mental decline linked with blood pressure   Levitra effective for ED due to spinal cord injury

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]